Tennessee HB0484 mandates coverage for biomarker testing in health benefit plans.
HB0484 amends Tennessee Code to require health benefit plans to cover biomarker testing for diagnosis, treatment, management, or monitoring of diseases. Coverage must be provided when supported by medical and scientific evidence, including FDA-approved tests, drug labels, Medicare determinations, or clinical guidelines. The bill also mandates timely approval or denial of prior authorization requests and access to a process for requesting exceptions to coverage policies.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.